Item 5.02. Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On January 26, 2021, Omnicell, Inc. ("Omnicell" or the "Company") announced that
Nhat H. Ngo will depart from his role as Executive Vice President, Marketing,
Strategy & Business Development, effective February 15, 2021. The Company would
like to thank Mr. Ngo for his many contributions during his Omnicell career and
for being instrumental in driving Omnicell's growth and transformation from a
dispensing cabinet company to today's market position as the technology-enabled
solutions partner for medication management across the care continuum.
Upon his departure, Mr. Ngo will be eligible for benefits under the Company's
existing Amended and Restated Severance Plan, which are described in the
Company's proxy statement filed with the Securities and Exchange Commission on
April 7, 2020.
In connection with Mr. Ngo's departure and an internal strategic reorganization,
the Company has moved Mr. Ngo's marketing and strategy functions under Scott
Seidelmann, the Company's Chief Commercial Officer, and the business development
function under Peter Kuipers, the Company's Chief Financial Officer.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses